Given that (R)-2HG competitively inhibits 2OG-dependent enzymes, many of which contribute to DNA and histone demethylation, there has been interest in whether methyltransferase inhibitors may be useful in treating IDH-mutant gliomas. The gene discussed is IDH2; the disease is glioma.